Global Peptide CDMO Market Research Report 2024(Status and Outlook)
Report Overview:
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
The Global Peptide CDMO Market Size was estimated at USD 3730.85 million in 2023 and is projected to reach USD 8629.68 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.
This report provides a deep insight into the global Peptide CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide CDMO market in any manner.
Global Peptide CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Market Segmentation (by Type)
APIs and Intermediates
FDF
Market Segmentation (by Application)
Commercial
Academic Research
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
The Global Peptide CDMO Market Size was estimated at USD 3730.85 million in 2023 and is projected to reach USD 8629.68 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.
This report provides a deep insight into the global Peptide CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide CDMO market in any manner.
Global Peptide CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Market Segmentation (by Type)
APIs and Intermediates
FDF
Market Segmentation (by Application)
Commercial
Academic Research
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Peptide CDMO Market
- Overview of the regional outlook of the Peptide CDMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peptide CDMO
1.2 Key Market Segments
1.2.1 Peptide CDMO Segment by Type
1.2.2 Peptide CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIDE CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptide CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peptide CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIDE CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Peptide CDMO Sales by Manufacturers (2019-2024)
3.2 Global Peptide CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peptide CDMO Sales Sites, Area Served, Product Type
3.6 Peptide CDMO Market Competitive Situation and Trends
3.6.1 Peptide CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO INDUSTRY CHAIN ANALYSIS
4.1 Peptide CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEPTIDE CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide CDMO Sales Market Share by Type (2019-2024)
6.3 Global Peptide CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Peptide CDMO Price by Type (2019-2024)
7 PEPTIDE CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide CDMO Market Sales by Application (2019-2024)
7.3 Global Peptide CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
8 PEPTIDE CDMO MARKET SEGMENTATION BY REGION
8.1 Global Peptide CDMO Sales by Region
8.1.1 Global Peptide CDMO Sales by Region
8.1.2 Global Peptide CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bachem
9.1.1 Bachem Peptide CDMO Basic Information
9.1.2 Bachem Peptide CDMO Product Overview
9.1.3 Bachem Peptide CDMO Product Market Performance
9.1.4 Bachem Business Overview
9.1.5 Bachem Peptide CDMO SWOT Analysis
9.1.6 Bachem Recent Developments
9.2 PolyPeptide
9.2.1 PolyPeptide Peptide CDMO Basic Information
9.2.2 PolyPeptide Peptide CDMO Product Overview
9.2.3 PolyPeptide Peptide CDMO Product Market Performance
9.2.4 PolyPeptide Business Overview
9.2.5 PolyPeptide Peptide CDMO SWOT Analysis
9.2.6 PolyPeptide Recent Developments
9.3 CordenPharma
9.3.1 CordenPharma Peptide CDMO Basic Information
9.3.2 CordenPharma Peptide CDMO Product Overview
9.3.3 CordenPharma Peptide CDMO Product Market Performance
9.3.4 CordenPharma Peptide CDMO SWOT Analysis
9.3.5 CordenPharma Business Overview
9.3.6 CordenPharma Recent Developments
9.4 AmbioPharm
9.4.1 AmbioPharm Peptide CDMO Basic Information
9.4.2 AmbioPharm Peptide CDMO Product Overview
9.4.3 AmbioPharm Peptide CDMO Product Market Performance
9.4.4 AmbioPharm Business Overview
9.4.5 AmbioPharm Recent Developments
9.5 USV Peptides
9.5.1 USV Peptides Peptide CDMO Basic Information
9.5.2 USV Peptides Peptide CDMO Product Overview
9.5.3 USV Peptides Peptide CDMO Product Market Performance
9.5.4 USV Peptides Business Overview
9.5.5 USV Peptides Recent Developments
9.6 Thermofischer
9.6.1 Thermofischer Peptide CDMO Basic Information
9.6.2 Thermofischer Peptide CDMO Product Overview
9.6.3 Thermofischer Peptide CDMO Product Market Performance
9.6.4 Thermofischer Business Overview
9.6.5 Thermofischer Recent Developments
9.7 Bio Basic
9.7.1 Bio Basic Peptide CDMO Basic Information
9.7.2 Bio Basic Peptide CDMO Product Overview
9.7.3 Bio Basic Peptide CDMO Product Market Performance
9.7.4 Bio Basic Business Overview
9.7.5 Bio Basic Recent Developments
9.8 JPT
9.8.1 JPT Peptide CDMO Basic Information
9.8.2 JPT Peptide CDMO Product Overview
9.8.3 JPT Peptide CDMO Product Market Performance
9.8.4 JPT Business Overview
9.8.5 JPT Recent Developments
9.9 Genscript
9.9.1 Genscript Peptide CDMO Basic Information
9.9.2 Genscript Peptide CDMO Product Overview
9.9.3 Genscript Peptide CDMO Product Market Performance
9.9.4 Genscript Business Overview
9.9.5 Genscript Recent Developments
9.10 Xinbang Pharma
9.10.1 Xinbang Pharma Peptide CDMO Basic Information
9.10.2 Xinbang Pharma Peptide CDMO Product Overview
9.10.3 Xinbang Pharma Peptide CDMO Product Market Performance
9.10.4 Xinbang Pharma Business Overview
9.10.5 Xinbang Pharma Recent Developments
9.11 ScinoPharm
9.11.1 ScinoPharm Peptide CDMO Basic Information
9.11.2 ScinoPharm Peptide CDMO Product Overview
9.11.3 ScinoPharm Peptide CDMO Product Market Performance
9.11.4 ScinoPharm Business Overview
9.11.5 ScinoPharm Recent Developments
9.12 SN Biopharm
9.12.1 SN Biopharm Peptide CDMO Basic Information
9.12.2 SN Biopharm Peptide CDMO Product Overview
9.12.3 SN Biopharm Peptide CDMO Product Market Performance
9.12.4 SN Biopharm Business Overview
9.12.5 SN Biopharm Recent Developments
9.13 CBL
9.13.1 CBL Peptide CDMO Basic Information
9.13.2 CBL Peptide CDMO Product Overview
9.13.3 CBL Peptide CDMO Product Market Performance
9.13.4 CBL Business Overview
9.13.5 CBL Recent Developments
9.14 Piramal Pharma
9.14.1 Piramal Pharma Peptide CDMO Basic Information
9.14.2 Piramal Pharma Peptide CDMO Product Overview
9.14.3 Piramal Pharma Peptide CDMO Product Market Performance
9.14.4 Piramal Pharma Business Overview
9.14.5 Piramal Pharma Recent Developments
9.15 CPC Scientific
9.15.1 CPC Scientific Peptide CDMO Basic Information
9.15.2 CPC Scientific Peptide CDMO Product Overview
9.15.3 CPC Scientific Peptide CDMO Product Market Performance
9.15.4 CPC Scientific Business Overview
9.15.5 CPC Scientific Recent Developments
10 PEPTIDE CDMO MARKET FORECAST BY REGION
10.1 Global Peptide CDMO Market Size Forecast
10.2 Global Peptide CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Peptide CDMO Market Size Forecast by Region
10.2.4 South America Peptide CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peptide CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peptide CDMO by Type (2025-2030)
11.1.2 Global Peptide CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peptide CDMO by Type (2025-2030)
11.2 Global Peptide CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Peptide CDMO Sales (Kilotons) Forecast by Application
11.2.2 Global Peptide CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peptide CDMO
1.2 Key Market Segments
1.2.1 Peptide CDMO Segment by Type
1.2.2 Peptide CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PEPTIDE CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peptide CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peptide CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PEPTIDE CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Peptide CDMO Sales by Manufacturers (2019-2024)
3.2 Global Peptide CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peptide CDMO Sales Sites, Area Served, Product Type
3.6 Peptide CDMO Market Competitive Situation and Trends
3.6.1 Peptide CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO INDUSTRY CHAIN ANALYSIS
4.1 Peptide CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PEPTIDE CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide CDMO Sales Market Share by Type (2019-2024)
6.3 Global Peptide CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Peptide CDMO Price by Type (2019-2024)
7 PEPTIDE CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide CDMO Market Sales by Application (2019-2024)
7.3 Global Peptide CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
8 PEPTIDE CDMO MARKET SEGMENTATION BY REGION
8.1 Global Peptide CDMO Sales by Region
8.1.1 Global Peptide CDMO Sales by Region
8.1.2 Global Peptide CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bachem
9.1.1 Bachem Peptide CDMO Basic Information
9.1.2 Bachem Peptide CDMO Product Overview
9.1.3 Bachem Peptide CDMO Product Market Performance
9.1.4 Bachem Business Overview
9.1.5 Bachem Peptide CDMO SWOT Analysis
9.1.6 Bachem Recent Developments
9.2 PolyPeptide
9.2.1 PolyPeptide Peptide CDMO Basic Information
9.2.2 PolyPeptide Peptide CDMO Product Overview
9.2.3 PolyPeptide Peptide CDMO Product Market Performance
9.2.4 PolyPeptide Business Overview
9.2.5 PolyPeptide Peptide CDMO SWOT Analysis
9.2.6 PolyPeptide Recent Developments
9.3 CordenPharma
9.3.1 CordenPharma Peptide CDMO Basic Information
9.3.2 CordenPharma Peptide CDMO Product Overview
9.3.3 CordenPharma Peptide CDMO Product Market Performance
9.3.4 CordenPharma Peptide CDMO SWOT Analysis
9.3.5 CordenPharma Business Overview
9.3.6 CordenPharma Recent Developments
9.4 AmbioPharm
9.4.1 AmbioPharm Peptide CDMO Basic Information
9.4.2 AmbioPharm Peptide CDMO Product Overview
9.4.3 AmbioPharm Peptide CDMO Product Market Performance
9.4.4 AmbioPharm Business Overview
9.4.5 AmbioPharm Recent Developments
9.5 USV Peptides
9.5.1 USV Peptides Peptide CDMO Basic Information
9.5.2 USV Peptides Peptide CDMO Product Overview
9.5.3 USV Peptides Peptide CDMO Product Market Performance
9.5.4 USV Peptides Business Overview
9.5.5 USV Peptides Recent Developments
9.6 Thermofischer
9.6.1 Thermofischer Peptide CDMO Basic Information
9.6.2 Thermofischer Peptide CDMO Product Overview
9.6.3 Thermofischer Peptide CDMO Product Market Performance
9.6.4 Thermofischer Business Overview
9.6.5 Thermofischer Recent Developments
9.7 Bio Basic
9.7.1 Bio Basic Peptide CDMO Basic Information
9.7.2 Bio Basic Peptide CDMO Product Overview
9.7.3 Bio Basic Peptide CDMO Product Market Performance
9.7.4 Bio Basic Business Overview
9.7.5 Bio Basic Recent Developments
9.8 JPT
9.8.1 JPT Peptide CDMO Basic Information
9.8.2 JPT Peptide CDMO Product Overview
9.8.3 JPT Peptide CDMO Product Market Performance
9.8.4 JPT Business Overview
9.8.5 JPT Recent Developments
9.9 Genscript
9.9.1 Genscript Peptide CDMO Basic Information
9.9.2 Genscript Peptide CDMO Product Overview
9.9.3 Genscript Peptide CDMO Product Market Performance
9.9.4 Genscript Business Overview
9.9.5 Genscript Recent Developments
9.10 Xinbang Pharma
9.10.1 Xinbang Pharma Peptide CDMO Basic Information
9.10.2 Xinbang Pharma Peptide CDMO Product Overview
9.10.3 Xinbang Pharma Peptide CDMO Product Market Performance
9.10.4 Xinbang Pharma Business Overview
9.10.5 Xinbang Pharma Recent Developments
9.11 ScinoPharm
9.11.1 ScinoPharm Peptide CDMO Basic Information
9.11.2 ScinoPharm Peptide CDMO Product Overview
9.11.3 ScinoPharm Peptide CDMO Product Market Performance
9.11.4 ScinoPharm Business Overview
9.11.5 ScinoPharm Recent Developments
9.12 SN Biopharm
9.12.1 SN Biopharm Peptide CDMO Basic Information
9.12.2 SN Biopharm Peptide CDMO Product Overview
9.12.3 SN Biopharm Peptide CDMO Product Market Performance
9.12.4 SN Biopharm Business Overview
9.12.5 SN Biopharm Recent Developments
9.13 CBL
9.13.1 CBL Peptide CDMO Basic Information
9.13.2 CBL Peptide CDMO Product Overview
9.13.3 CBL Peptide CDMO Product Market Performance
9.13.4 CBL Business Overview
9.13.5 CBL Recent Developments
9.14 Piramal Pharma
9.14.1 Piramal Pharma Peptide CDMO Basic Information
9.14.2 Piramal Pharma Peptide CDMO Product Overview
9.14.3 Piramal Pharma Peptide CDMO Product Market Performance
9.14.4 Piramal Pharma Business Overview
9.14.5 Piramal Pharma Recent Developments
9.15 CPC Scientific
9.15.1 CPC Scientific Peptide CDMO Basic Information
9.15.2 CPC Scientific Peptide CDMO Product Overview
9.15.3 CPC Scientific Peptide CDMO Product Market Performance
9.15.4 CPC Scientific Business Overview
9.15.5 CPC Scientific Recent Developments
10 PEPTIDE CDMO MARKET FORECAST BY REGION
10.1 Global Peptide CDMO Market Size Forecast
10.2 Global Peptide CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peptide CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Peptide CDMO Market Size Forecast by Region
10.2.4 South America Peptide CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peptide CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peptide CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peptide CDMO by Type (2025-2030)
11.1.2 Global Peptide CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peptide CDMO by Type (2025-2030)
11.2 Global Peptide CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Peptide CDMO Sales (Kilotons) Forecast by Application
11.2.2 Global Peptide CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide CDMO Market Size Comparison by Region (M USD)
Table 5. Global Peptide CDMO Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Peptide CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peptide CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peptide CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO as of 2022)
Table 10. Global Market Peptide CDMO Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peptide CDMO Sales Sites and Area Served
Table 12. Manufacturers Peptide CDMO Product Type
Table 13. Global Peptide CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide CDMO Market Challenges
Table 22. Global Peptide CDMO Sales by Type (Kilotons)
Table 23. Global Peptide CDMO Market Size by Type (M USD)
Table 24. Global Peptide CDMO Sales (Kilotons) by Type (2019-2024)
Table 25. Global Peptide CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Peptide CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Peptide CDMO Market Size Share by Type (2019-2024)
Table 28. Global Peptide CDMO Price (USD/Ton) by Type (2019-2024)
Table 29. Global Peptide CDMO Sales (Kilotons) by Application
Table 30. Global Peptide CDMO Market Size by Application
Table 31. Global Peptide CDMO Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Peptide CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Peptide CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Peptide CDMO Market Share by Application (2019-2024)
Table 35. Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Peptide CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 43. Bachem Peptide CDMO Basic Information
Table 44. Bachem Peptide CDMO Product Overview
Table 45. Bachem Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bachem Business Overview
Table 47. Bachem Peptide CDMO SWOT Analysis
Table 48. Bachem Recent Developments
Table 49. PolyPeptide Peptide CDMO Basic Information
Table 50. PolyPeptide Peptide CDMO Product Overview
Table 51. PolyPeptide Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide Peptide CDMO SWOT Analysis
Table 54. PolyPeptide Recent Developments
Table 55. CordenPharma Peptide CDMO Basic Information
Table 56. CordenPharma Peptide CDMO Product Overview
Table 57. CordenPharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. CordenPharma Peptide CDMO SWOT Analysis
Table 59. CordenPharma Business Overview
Table 60. CordenPharma Recent Developments
Table 61. AmbioPharm Peptide CDMO Basic Information
Table 62. AmbioPharm Peptide CDMO Product Overview
Table 63. AmbioPharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AmbioPharm Business Overview
Table 65. AmbioPharm Recent Developments
Table 66. USV Peptides Peptide CDMO Basic Information
Table 67. USV Peptides Peptide CDMO Product Overview
Table 68. USV Peptides Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. USV Peptides Business Overview
Table 70. USV Peptides Recent Developments
Table 71. Thermofischer Peptide CDMO Basic Information
Table 72. Thermofischer Peptide CDMO Product Overview
Table 73. Thermofischer Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Thermofischer Business Overview
Table 75. Thermofischer Recent Developments
Table 76. Bio Basic Peptide CDMO Basic Information
Table 77. Bio Basic Peptide CDMO Product Overview
Table 78. Bio Basic Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bio Basic Business Overview
Table 80. Bio Basic Recent Developments
Table 81. JPT Peptide CDMO Basic Information
Table 82. JPT Peptide CDMO Product Overview
Table 83. JPT Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. JPT Business Overview
Table 85. JPT Recent Developments
Table 86. Genscript Peptide CDMO Basic Information
Table 87. Genscript Peptide CDMO Product Overview
Table 88. Genscript Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Genscript Business Overview
Table 90. Genscript Recent Developments
Table 91. Xinbang Pharma Peptide CDMO Basic Information
Table 92. Xinbang Pharma Peptide CDMO Product Overview
Table 93. Xinbang Pharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Xinbang Pharma Business Overview
Table 95. Xinbang Pharma Recent Developments
Table 96. ScinoPharm Peptide CDMO Basic Information
Table 97. ScinoPharm Peptide CDMO Product Overview
Table 98. ScinoPharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ScinoPharm Business Overview
Table 100. ScinoPharm Recent Developments
Table 101. SN Biopharm Peptide CDMO Basic Information
Table 102. SN Biopharm Peptide CDMO Product Overview
Table 103. SN Biopharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. SN Biopharm Business Overview
Table 105. SN Biopharm Recent Developments
Table 106. CBL Peptide CDMO Basic Information
Table 107. CBL Peptide CDMO Product Overview
Table 108. CBL Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. CBL Business Overview
Table 110. CBL Recent Developments
Table 111. Piramal Pharma Peptide CDMO Basic Information
Table 112. Piramal Pharma Peptide CDMO Product Overview
Table 113. Piramal Pharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Piramal Pharma Business Overview
Table 115. Piramal Pharma Recent Developments
Table 116. CPC Scientific Peptide CDMO Basic Information
Table 117. CPC Scientific Peptide CDMO Product Overview
Table 118. CPC Scientific Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. CPC Scientific Business Overview
Table 120. CPC Scientific Recent Developments
Table 121. Global Peptide CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Peptide CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Peptide CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Peptide CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Peptide CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Peptide CDMO Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Peptide CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Peptide CDMO Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Peptide CDMO Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Peptide CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide CDMO Market Size Comparison by Region (M USD)
Table 5. Global Peptide CDMO Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Peptide CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peptide CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peptide CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO as of 2022)
Table 10. Global Market Peptide CDMO Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peptide CDMO Sales Sites and Area Served
Table 12. Manufacturers Peptide CDMO Product Type
Table 13. Global Peptide CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide CDMO Market Challenges
Table 22. Global Peptide CDMO Sales by Type (Kilotons)
Table 23. Global Peptide CDMO Market Size by Type (M USD)
Table 24. Global Peptide CDMO Sales (Kilotons) by Type (2019-2024)
Table 25. Global Peptide CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Peptide CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Peptide CDMO Market Size Share by Type (2019-2024)
Table 28. Global Peptide CDMO Price (USD/Ton) by Type (2019-2024)
Table 29. Global Peptide CDMO Sales (Kilotons) by Application
Table 30. Global Peptide CDMO Market Size by Application
Table 31. Global Peptide CDMO Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Peptide CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Peptide CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Peptide CDMO Market Share by Application (2019-2024)
Table 35. Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Peptide CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Peptide CDMO Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Peptide CDMO Sales by Region (2019-2024) & (Kilotons)
Table 43. Bachem Peptide CDMO Basic Information
Table 44. Bachem Peptide CDMO Product Overview
Table 45. Bachem Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bachem Business Overview
Table 47. Bachem Peptide CDMO SWOT Analysis
Table 48. Bachem Recent Developments
Table 49. PolyPeptide Peptide CDMO Basic Information
Table 50. PolyPeptide Peptide CDMO Product Overview
Table 51. PolyPeptide Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide Peptide CDMO SWOT Analysis
Table 54. PolyPeptide Recent Developments
Table 55. CordenPharma Peptide CDMO Basic Information
Table 56. CordenPharma Peptide CDMO Product Overview
Table 57. CordenPharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. CordenPharma Peptide CDMO SWOT Analysis
Table 59. CordenPharma Business Overview
Table 60. CordenPharma Recent Developments
Table 61. AmbioPharm Peptide CDMO Basic Information
Table 62. AmbioPharm Peptide CDMO Product Overview
Table 63. AmbioPharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AmbioPharm Business Overview
Table 65. AmbioPharm Recent Developments
Table 66. USV Peptides Peptide CDMO Basic Information
Table 67. USV Peptides Peptide CDMO Product Overview
Table 68. USV Peptides Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. USV Peptides Business Overview
Table 70. USV Peptides Recent Developments
Table 71. Thermofischer Peptide CDMO Basic Information
Table 72. Thermofischer Peptide CDMO Product Overview
Table 73. Thermofischer Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Thermofischer Business Overview
Table 75. Thermofischer Recent Developments
Table 76. Bio Basic Peptide CDMO Basic Information
Table 77. Bio Basic Peptide CDMO Product Overview
Table 78. Bio Basic Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bio Basic Business Overview
Table 80. Bio Basic Recent Developments
Table 81. JPT Peptide CDMO Basic Information
Table 82. JPT Peptide CDMO Product Overview
Table 83. JPT Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. JPT Business Overview
Table 85. JPT Recent Developments
Table 86. Genscript Peptide CDMO Basic Information
Table 87. Genscript Peptide CDMO Product Overview
Table 88. Genscript Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Genscript Business Overview
Table 90. Genscript Recent Developments
Table 91. Xinbang Pharma Peptide CDMO Basic Information
Table 92. Xinbang Pharma Peptide CDMO Product Overview
Table 93. Xinbang Pharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Xinbang Pharma Business Overview
Table 95. Xinbang Pharma Recent Developments
Table 96. ScinoPharm Peptide CDMO Basic Information
Table 97. ScinoPharm Peptide CDMO Product Overview
Table 98. ScinoPharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ScinoPharm Business Overview
Table 100. ScinoPharm Recent Developments
Table 101. SN Biopharm Peptide CDMO Basic Information
Table 102. SN Biopharm Peptide CDMO Product Overview
Table 103. SN Biopharm Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. SN Biopharm Business Overview
Table 105. SN Biopharm Recent Developments
Table 106. CBL Peptide CDMO Basic Information
Table 107. CBL Peptide CDMO Product Overview
Table 108. CBL Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. CBL Business Overview
Table 110. CBL Recent Developments
Table 111. Piramal Pharma Peptide CDMO Basic Information
Table 112. Piramal Pharma Peptide CDMO Product Overview
Table 113. Piramal Pharma Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Piramal Pharma Business Overview
Table 115. Piramal Pharma Recent Developments
Table 116. CPC Scientific Peptide CDMO Basic Information
Table 117. CPC Scientific Peptide CDMO Product Overview
Table 118. CPC Scientific Peptide CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. CPC Scientific Business Overview
Table 120. CPC Scientific Recent Developments
Table 121. Global Peptide CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Peptide CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Peptide CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Peptide CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Peptide CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Peptide CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Peptide CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Peptide CDMO Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Peptide CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Peptide CDMO Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Peptide CDMO Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Peptide CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peptide CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide CDMO Market Size (M USD), 2019-2030
Figure 5. Global Peptide CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Peptide CDMO Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide CDMO Market Size by Country (M USD)
Figure 11. Peptide CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Peptide CDMO Revenue Share by Manufacturers in 2023
Figure 13. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide CDMO Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide CDMO Market Share by Type
Figure 18. Sales Market Share of Peptide CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Peptide CDMO by Type in 2023
Figure 20. Market Size Share of Peptide CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Peptide CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide CDMO Market Share by Application
Figure 24. Global Peptide CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Peptide CDMO Sales Market Share by Application in 2023
Figure 26. Global Peptide CDMO Market Share by Application (2019-2024)
Figure 27. Global Peptide CDMO Market Share by Application in 2023
Figure 28. Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peptide CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Peptide CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Peptide CDMO Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Peptide CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Peptide CDMO Sales Market Share by Country in 2023
Figure 37. Germany Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Peptide CDMO Sales Market Share by Region in 2023
Figure 44. China Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 50. South America Peptide CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Peptide CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Peptide CDMO Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Peptide CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peptide CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peptide CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Peptide CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Peptide CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Peptide CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide CDMO Market Size (M USD), 2019-2030
Figure 5. Global Peptide CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Peptide CDMO Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide CDMO Market Size by Country (M USD)
Figure 11. Peptide CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Peptide CDMO Revenue Share by Manufacturers in 2023
Figure 13. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide CDMO Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide CDMO Market Share by Type
Figure 18. Sales Market Share of Peptide CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Peptide CDMO by Type in 2023
Figure 20. Market Size Share of Peptide CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Peptide CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide CDMO Market Share by Application
Figure 24. Global Peptide CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Peptide CDMO Sales Market Share by Application in 2023
Figure 26. Global Peptide CDMO Market Share by Application (2019-2024)
Figure 27. Global Peptide CDMO Market Share by Application in 2023
Figure 28. Global Peptide CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peptide CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Peptide CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Peptide CDMO Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Peptide CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Peptide CDMO Sales Market Share by Country in 2023
Figure 37. Germany Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Peptide CDMO Sales Market Share by Region in 2023
Figure 44. China Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 50. South America Peptide CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Peptide CDMO Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Peptide CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Peptide CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Peptide CDMO Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Peptide CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peptide CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peptide CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Peptide CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Peptide CDMO Market Share Forecast by Application (2025-2030)
